Kuur Therapeutics announces first patients dosed with allogeneic CAR-NKT cell therapy
This article was originally published here
“This is an important day, as the initiation and dosing of the first patients in the ANCHOR phase 1 clinical study marks the first time that patients have
The post Kuur Therapeutics announces first patients dosed with allogeneic CAR-NKT cell therapy appeared first on Pharmaceutical Business review.
Leave a Reply
Want to join the discussion?Feel free to contribute!